Despite the marketshare gains Cardiovascular Systems (CSII) has made with its Diamondback and...

|About: Cardiovascular Systems, Inc. (CSII)|By:, SA News Editor

Despite the marketshare gains Cardiovascular Systems (CSII) has made with its Diamondback and Stealth devices for treating narrowed or blocked arteries in the leg, the real value in the company may lie in its takeout potential, says Seeking Alpha contributor Stephen Simpson. CR Bard, Cook, BSX, JNJ, MDT and ABT all have sales forces in the peripheral treatment space, making them solid candidates for a possible buyout of CSII.